Status:
UNKNOWN
Comparation Between Needles for EUS-guided Sampling of Solid Pancreatic Lesions
Lead Sponsor:
Instituto do Cancer do Estado de São Paulo
Collaborating Sponsors:
Boston Scientific Corporation
Conditions:
Pancreatic Neoplasms
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a randomized study in order to compare the diagnostic yield (primary outcome) of EUS-guided sampling of pancreatic solid lesions obtained with the 25-gauge Franseen and the 25-gauge standard n...
Detailed Description
This is a randomized trial conducted at a unique center. The aim of this study is to compare the diagnostic yield (primary outcome) of EUS-guided sampling of pancreatic solid lesions obtained with the...
Eligibility Criteria
Inclusion
- \- solid pancreatic lesion larger than 15 mm
Exclusion
- pancreatic cystic lesion
- lesion not detected in EUS
- abnormal coagulation parameters (INR\> 2, platelet count \< 50,000)
Key Trial Info
Start Date :
November 26 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2023
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04877340
Start Date
November 26 2020
End Date
April 1 2023
Last Update
May 7 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ICESP
São Paulo, São Paulo, Brazil, 01246-000